Registrations open!
HER2 image analysis for breast cancer in routine use at Dutch laboratories
Wednesday 9th April 2025
Hosted in conjunction with UMC Utrecht/Utrecht University
This event brings together breast pathologists and lab scientists to discuss the latest advancements in HER2 analysis, with experience of analysis used in Dutch routine pathology laboratories. Visiopharm will also showcase our new HER2 algorithm, designed to further enhance accuracy and efficiency in your diagnostic workflows including for HER2 low assessment.
Key learnings:
- Challenges with HER2 assessment
- Requirements in Dutch market for HER2 low
- Staining issues for HER2 and how to standardise
When and where
Date / Time
Wednesday 9th April 2025, 12:30pm–5:15pm
Location
UMC Utrecht, Q.01.226 Auditorium
Directions:
• From the main entrance of UMC Utrecht, turn right to Radiology (reception 19)
• Follow the walking direction (for reception 19 to the right)
• Beyond the RVS elevators on your left, go to the left
• Turn right at the end of this corridor
• Continue straight on (through the swinging doors) until the end of this corridor
• Go to the right and you will arrive at the Auditorium
Please note: The meeting is held in English and is on-site only
Agenda
| Time | Program | Speaker(s) |
| 12:30-13:30 | Lunch and networking | |
| 13:30-13:45 | Welcome address | Carmen van Dooijeweert, UMC Utrecht and Matthew Burke, Visiopharm |
| 13:45-14:15 | Charting New Territories: AI in HER2 Immunohistochemistry with Qualitopix | Sven van Kempen, Research Technician based at UMC Utrecht |
| 14:15-14:45 | Heterogenous inter- and intra-laboratory HER2 expression and its lower limit of detection | Nils 't Hart, Pathologist, Isala Hospital |
| 14:45-15:15 | Presentation on HER2 analysis | Mateusz Tylicki, Visiopharm |
| 15:15-15:30 | Break | |
| 15:30-16:00 | AI in the production process, the road to a green business case in the breast cancer chain | Gerard van Zuilen, DNA Pathology |
| 16:00-16:30 | Discussion session | |
| 16:30-17:15 | Closing remarks, followed by reception and networking |